| P50 | author | Maria Helena Galdino Figueiredo-Carvalho | Q42320587 |
| | Leonardo Silva Barbedo | Q42320588 |
| | Rodrigo Almeida-Paes | Q59690913 |
| | Livia de Souza Ramos | Q87164863 |
| | André Luis Souza Dos Santos | Q88791028 |
| | Rosely Maria Zancopé-Oliveira | Q88791030 |
| P2093 | author name string | Jean Carlos Almeida de Oliveira | |
| P2860 | cites work | Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management | Q38254290 |
| | Rapid discrimination between Candida glabrata, Candida nivariensis, and Candida bracarensis by use of a singleplex PCR. | Q38285340 |
| | Intracellular survival of Candida glabrata in macrophages: immune evasion and persistence | Q38525376 |
| | Candida glabrata survives and replicates in human osteoblasts | Q38778635 |
| | Species distribution and antifungal susceptibility profile of Candida isolates from bloodstream infections in Lima, Peru. | Q38927031 |
| | Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells | Q39077878 |
| | Different classes of hydrolytic enzymes produced by multidrug-resistant yeasts comprising the Candida haemulonii complex. | Q40565004 |
| | Contribution of Aspartic Proteases in Candida Virulence. Protease Inhibitors against Candida Infections | Q40579444 |
| | Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes | Q40593859 |
| | Analysis of virulence factors and in vivo biofilm-forming capacity of Yarrowia lipolytica isolated from patients with fungemia | Q40605452 |
| | Human neutrophils dump Candida glabrata after intracellular killing | Q40991649 |
| | Phospholipase and Aspartyl Proteinase Activities of Candida Species Causing Vulvovaginal Candidiasis in Patients with Type 2 Diabetes Mellitus. | Q41191839 |
| | A novel Candida glabrata cell wall associated serine protease | Q41524122 |
| | Micafungin alone and in combination therapy with deferasirox against Pythium insidiosum | Q41627071 |
| | Elevated chitin content reduces the susceptibility of Candida species to caspofungin | Q41843284 |
| | Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009) | Q42169461 |
| | The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods | Q42222742 |
| | Carbohydrate esterase family 4 enzymes: substrate specificity | Q44367075 |
| | Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals | Q45350702 |
| | Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland | Q45738655 |
| | First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen. | Q45922446 |
| | Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species. | Q45957754 |
| | Comparison of the hemolytic activity between C. albicans and non-albicans Candida species | Q46069346 |
| | Trends in antifungal susceptibility and virulence of Candida spp. from the nasolacrimal duct of horses | Q46651663 |
| | Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey | Q46862646 |
| | Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp. | Q46905271 |
| | Candida albicans isolates from a Malaysian hospital exhibit more potent phospholipase and haemolysin activities than non-albicans Candida isolates | Q46932559 |
| | Phenotypical properties associated with virulence from clinical isolates belonging to the Candida parapsilosis complex | Q46985812 |
| | EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). | Q47568809 |
| | Molecular and biotechnological aspects of microbial proteases | Q24548591 |
| | Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans | Q24550731 |
| | Essential metals at the host-pathogen interface: nutritional immunity and micronutrient assimilation by human fungal pathogens | Q26799095 |
| | Yapsins are a family of aspartyl proteases required for cell wall integrity in Saccharomyces cerevisiae. | Q27937998 |
| | Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors | Q28344744 |
| | Echinocandin resistance: an emerging clinical problem? | Q28544739 |
| | Candida nivariensis in comparison to different phenotypes of Candida glabrata | Q30856083 |
| | Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus | Q30998443 |
| | Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata | Q31029368 |
| | Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia | Q33783807 |
| | Undocumented Latino immigrant men in the United States: Policy and practice considerations | Q33859416 |
| | Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. | Q34165039 |
| | Characterization of metalloprotease and serine protease activities in batch CHO cell cultures: control of human recombinant IFN-γ proteolysis by addition of iron citrate | Q34177054 |
| | The changing epidemiology of healthcare-associated candidemia over three decades | Q34266632 |
| | Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. | Q34313668 |
| | Hydrolytic enzymes as virulence factors of Candida albicans | Q34464426 |
| | Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America | Q34505582 |
| | Epidemiology of candidemia in Latin America: a laboratory-based survey | Q34635088 |
| | Comparison Between Virulence Factors of Candida albicans and Non-Albicans Species of Candida Isolated from Genitourinary Tract | Q34909936 |
| | Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpoints | Q34977249 |
| | Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters | Q35120105 |
| | Comparative Study of Esterase and Hemolytic Activities in Clinically Important Candida Species, Isolated From Oral Cavity of Diabetic and Non-diabetic Individuals. | Q35276257 |
| | Phytase enzymology, applications, and biotechnology | Q35608599 |
| | The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata | Q36172500 |
| | A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs. | Q36445833 |
| | Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations | Q36856930 |
| | Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program | Q37669855 |
| | Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance | Q37875198 |
| | Aspartic proteinases of Candida spp.: role in pathogenicity and antifungal resistance. | Q38111859 |
| | The oxidative stress response of the opportunistic fungal pathogen Candida glabrata. | Q38165646 |
| | Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013. | Q38199454 |
| | Multidrug resistance in fungi: regulation of transporter-encoding gene expression | Q38209314 |
| | A systematic analysis reveals an essential role for high-affinity iron uptake system, haemolysin and CFEM domain-containing protein in iron homoeostasis and virulence in Candida glabrata. | Q52651602 |
| | Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure. | Q54375674 |
| | A comparison of secretory proteinases from different strains of Candida albicans. | Q54513063 |
| | Looking for Candida nivariensis and C. bracarensis among a large Italian collection of C. glabrata isolates: results of the FIMUA working group. | Q55056871 |
| | Plate method for detection of phospholipase activity in Candida albicans | Q70222244 |
| | Esterase activity in various Candida species | Q74585608 |
| | The bZip transcription factor Cgap1p is involved in multidrug resistance and required for activation of multidrug transporter gene CgFLR1 in Candida glabrata | Q79258120 |
| | Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis | Q84592815 |
| | Differential phytate utilization in Candida species | Q84597727 |
| | Virulence of South African Candida albicans strains isolated from different clinical samples | Q87373109 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Candida glabrata | Q139137 |
| P304 | page(s) | 8952878 | |
| P577 | publication date | 2017-07-26 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of Candida glabrata | |
| P478 | volume | 2017 | |